These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38141545)

  • 1. Bidirectional effect of poverty and treatment-resistant diseases: The case of antimicrobial resistance in middle and low-income countries.
    Rahim F
    J Infect Public Health; 2024 Feb; 17(2):283-285. PubMed ID: 38141545
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial resistance data, frugal sequencing, and low-income countries in Africa.
    Aruhomukama D
    Lancet Infect Dis; 2022 Jul; 22(7):933-934. PubMed ID: 35594898
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of poverty in antimicrobial resistance.
    Planta MB
    J Am Board Fam Med; 2007; 20(6):533-9. PubMed ID: 17954860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.
    Mahadi AR
    Front Public Health; 2021; 9():770593. PubMed ID: 34976929
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: a systematic review and meta-analysis.
    Droz N; Hsia Y; Ellis S; Dramowski A; Sharland M; Basmaci R
    Antimicrob Resist Infect Control; 2019; 8():207. PubMed ID: 31893041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis.
    Alsan M; Schoemaker L; Eggleston K; Kammili N; Kolli P; Bhattacharya J
    Lancet Infect Dis; 2015 Oct; 15(10):1203-1210. PubMed ID: 26164481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poverty and prevalence of antimicrobial resistance in invasive isolates.
    Alvarez-Uria G; Gandra S; Laxminarayan R
    Int J Infect Dis; 2016 Nov; 52():59-61. PubMed ID: 27717858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries.
    de Kraker MEA
    PLoS Med; 2023 Jul; 20(7):e1004262. PubMed ID: 37436835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Social Media as a Tool to Reduce Antibiotic Usage: A Neglected Approach to Combat Antimicrobial Resistance in Low and Middle Income Countries.
    Acharya KP; Subedi D
    Front Public Health; 2020; 8():558576. PubMed ID: 33363074
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial Resistance in the Tropics.
    Semret M; Haraoui LP
    Infect Dis Clin North Am; 2019 Mar; 33(1):231-245. PubMed ID: 30712764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using 'smart regulation' to tackle antimicrobial resistance in low-income and middle-income countries.
    Porter G; Joshi J; Bhullar L; Kotwani A;
    BMJ Glob Health; 2020; 5(1):e001864. PubMed ID: 32133168
    [No Abstract]   [Full Text] [Related]  

  • 12. A view on antimicrobial resistance in developing countries and responsible risk factors.
    Byarugaba DK
    Int J Antimicrob Agents; 2004 Aug; 24(2):105-10. PubMed ID: 15288307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoonotic sources and the spread of antimicrobial resistance from the perspective of low and middle-income countries.
    Olaru ID; Walther B; Schaumburg F
    Infect Dis Poverty; 2023 Jun; 12(1):59. PubMed ID: 37316938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list.
    Savoldi A; Carrara E; Gladstone BP; Azzini AM; Göpel S; Tacconelli E
    J Antimicrob Chemother; 2019 Dec; 74(12):3619-3625. PubMed ID: 31730162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing bespoke antimicrobials to combat antimicrobial resistance in low- and middle-income countries: A critical appraisal of clinical utility in the elderly.
    MohanaSundaram A; Sathanantham ST; Sah R; Apostolopoulos V
    Maturitas; 2023 Apr; 170():74-75. PubMed ID: 36494242
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial resistance: learning lessons from antiparasitic, antibacterial and antimycobacterial drug resistance in low-income settings.
    Whitty CJM
    Trans R Soc Trop Med Hyg; 2019 Mar; 113(3):105-107. PubMed ID: 30715509
    [No Abstract]   [Full Text] [Related]  

  • 17. BSAC Vanguard Series: AMR diagnostics in light of evolving technologies and access in low- and middle-income countries.
    Berman D; Neale R
    J Antimicrob Chemother; 2021 Dec; 77(1):3-4. PubMed ID: 34791279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combating antimicrobial resistance through vaccines in children from low- and middle-income countries-a call for research.
    Gingaras C; Collins E
    J Trop Pediatr; 2024 Apr; 70(3):. PubMed ID: 38622730
    [No Abstract]   [Full Text] [Related]  

  • 20. Systematic Review of Antibiotic Resistance Rates Among Gram-Negative Bacteria in Children With Sepsis in Resource-Limited Countries.
    Le Doare K; Bielicki J; Heath PT; Sharland M
    J Pediatric Infect Dis Soc; 2015 Mar; 4(1):11-20. PubMed ID: 26407352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.